Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000467356 | SCV000561627 | benign | Hypertrophic cardiomyopathy 19 | 2024-01-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000618962 | SCV000739904 | uncertain significance | Cardiovascular phenotype | 2013-07-10 | criteria provided, single submitter | clinical testing | There is insufficient or conflicting evidence for classification of this alteration. |
Center for Genomics, |
RCV003227765 | SCV003924136 | uncertain significance | Hypertrophic cardiomyopathy | 2021-03-30 | criteria provided, single submitter | clinical testing | CALR3 NM_145046.4 exon 7 p.Thr283Ile (c.848C>T): This variant has not been reported in the literature but is present in 0.5% (126/24970) of African alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/19-16593331-G-A). This variant is present in ClinVar (Variation ID:416239). Evolutionary conservation and computational predictive tools for this variant are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001700129 | SCV005039598 | likely benign | not specified | 2024-03-11 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001700129 | SCV001920803 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001703179 | SCV001932970 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001703179 | SCV001969389 | likely benign | not provided | no assertion criteria provided | clinical testing |